Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas - Afify,A.M.; Ferguson,A.W.; Davila,R.M.; Werness,B.A. (Appl Immunohistochem Mol Morphol, 2001)